April 4th 2025, 7:00pm
CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.
March 27th 2025, 7:00pm
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
March 26th 2025, 7:00pm
A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.
August 29th 2024, 7:00pm
Patients with multiple myeloma now have several available treatment options, so it’s important to have answers to some of the frequently asked questions.
August 27th 2024, 7:22pm
Questions about multiple myeloma regarding treatment options, bone strength and other associated comorbidities were answered by an expert.
June 20th 2024, 6:00pm
During the CURE® Educated Patient® Multiple Myeloma Summit, one expert explained the push to make CAR-T cell therapy available for patients sooner.
June 14th 2024, 7:00pm
As part of the CURE® Educated Patient® Summit, one expert reviewed the landscape of bispecific antibodies, such as Tecvayli, for multiple myeloma.
June 13th 2024, 7:00pm
Quality of life may temporarily worsen after patients with myeloma receive stem cell transplants, said an expert at the Educated Patient® Multiple Myeloma Summit.
June 11th 2024, 7:23pm
New drug combinations and sequences are being investigated and may improve outcomes for patients with newly diagnosed myeloma, an expert explained at the Educated Patient® Multiple Myeloma Summit.
April 29th 2023, 3:00pm
Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.
A Unicorn Among Us
Understanding Supportive Care Needs in Younger Women With Cancer
Diving Into Every FDA Drug Approval for Cancer Care During May 2025
Being in the Present Moment With Multiple Myeloma